Annual CFI
-$54.30 K
-$7.61 M-100.72%
December 31, 2023
Summary
- As of February 8, 2025, EPRX annual cash flow from investing activities is -$54.30 thousand, with the most recent change of -$7.61 million (-100.72%) on December 31, 2023.
- During the last 3 years, EPRX annual CFI has fallen by -$72.70 thousand (-395.11%).
- EPRX annual CFI is now -100.72% below its all-time high of $7.56 million, reached on December 31, 2022.
Performance
EPRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$42.30 K
-$60.00 K-338.98%
September 1, 2024
Summary
- As of February 8, 2025, EPRX quarterly cash flow from investing activities is -$42.30 thousand, with the most recent change of -$60.00 thousand (-338.98%) on September 1, 2024.
- Over the past year, EPRX quarterly CFI has dropped by -$60.00 thousand (-338.98%).
- EPRX quarterly CFI is now -100.26% below its all-time high of $16.57 million, reached on December 1, 2022.
Performance
EPRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$80.80 K
-$32.70 K-67.98%
September 1, 2024
Summary
- As of February 8, 2025, EPRX TTM cash flow from investing activities is -$80.80 thousand, with the most recent change of -$32.70 thousand (-67.98%) on September 1, 2024.
- Over the past year, EPRX TTM CFI has dropped by -$32.70 thousand (-67.98%).
- EPRX TTM CFI is now -100.48% below its all-time high of $16.93 million, reached on June 30, 2023.
Performance
EPRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
EPRX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.7% | -339.0% | -68.0% |
| 3 y3 years | -395.1% | +99.4% | +99.3% |
| 5 y5 years | +50.4% | -178.3% | -431.6% |
EPRX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.7% | +99.5% | -100.3% | +99.4% | -100.5% | +99.4% |
| 5 y | 5-year | -100.7% | +99.5% | -100.3% | +99.4% | -100.5% | +99.4% |
| alltime | all time | -100.7% | +99.5% | -100.3% | +99.4% | -100.5% | +99.4% |
Eupraxia Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$42.30 K(-339.0%) | -$80.80 K(+68.0%) |
| Jun 2024 | - | $17.70 K(-360.3%) | -$48.10 K(-33.3%) |
| Mar 2024 | - | -$6800.00(-86.2%) | -$72.10 K(-1.8%) |
| Dec 2023 | -$54.30 K(-100.7%) | -$49.40 K(+414.6%) | -$73.40 K(-100.4%) |
| Sep 2023 | - | -$9600.00(+52.4%) | $16.55 M(-2.3%) |
| Jun 2023 | - | -$6300.00(-22.2%) | $16.93 M(+72.2%) |
| Mar 2023 | - | -$8100.00(-100.0%) | $9.83 M(-0.0%) |
| Dec 2022 | $7.56 M | - | - |
| Dec 2022 | - | $16.57 M(+4332.1%) | $9.83 M(-171.2%) |
| Sep 2022 | - | $373.90 K(-105.3%) | -$13.81 M(-3.8%) |
| Jun 2022 | - | -$7.11 M(>+9900.0%) | -$14.36 M(+96.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5400.00(-99.9%) | -$7.32 M(-35.4%) |
| Dec 2021 | -$11.53 M(<-9900.0%) | -$7.07 M(+3963.9%) | -$11.33 M(+166.1%) |
| Sep 2021 | - | -$174.00 K(+136.7%) | -$4.26 M(+4.3%) |
| Jun 2021 | - | -$73.50 K(-98.2%) | -$4.09 M(+2.7%) |
| Mar 2021 | - | -$4.01 M(<-9900.0%) | -$3.98 M(<-9900.0%) |
| Dec 2020 | $18.40 K(-101.3%) | $2200.00(+633.3%) | $19.30 K(+12.9%) |
| Sep 2020 | - | $300.00(-99.1%) | $17.10 K(+1.8%) |
| Jun 2020 | - | $32.00 K(-310.5%) | $16.80 K(-210.5%) |
| Mar 2020 | - | -$15.20 K | -$15.20 K |
| Dec 2019 | -$1.43 M(+1203.9%) | - | - |
| Dec 2018 | -$109.50 K(-54.9%) | - | - |
| Dec 2017 | -$242.80 K | - | - |
FAQ
- What is Eupraxia Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual CFI year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly CFI year-on-year change?
- What is Eupraxia Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals TTM CFI year-on-year change?
What is Eupraxia Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of EPRX is -$54.30 K
What is the all time high annual CFI for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual cash flow from investing activities is $7.56 M
What is Eupraxia Pharmaceuticals annual CFI year-on-year change?
Over the past year, EPRX annual cash flow from investing activities has changed by -$7.61 M (-100.72%)
What is Eupraxia Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of EPRX is -$42.30 K
What is the all time high quarterly CFI for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly cash flow from investing activities is $16.57 M
What is Eupraxia Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, EPRX quarterly cash flow from investing activities has changed by -$60.00 K (-338.98%)
What is Eupraxia Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of EPRX is -$80.80 K
What is the all time high TTM CFI for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high TTM cash flow from investing activities is $16.93 M
What is Eupraxia Pharmaceuticals TTM CFI year-on-year change?
Over the past year, EPRX TTM cash flow from investing activities has changed by -$32.70 K (-67.98%)